A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer

Clinical trial NCT03655353 · UNKNOWN

Trial details

NCT number: NCT03655353
Sponsor: Henrik Lindman
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

HER2-positive Breast Cancer

Start date: 2018-08-22
Primary completion: 2024-11-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.